Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

OxyContin

OxyContin, an narcotic analgesic produced by Purdue Pharma LP, nets $3m in sales annually, placing it 8th in the world for annual sales. OxyContin in the brand name for oxycodone, and is similar t...

Eligard

Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Lyxumia

Lyxumia® is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) for the treatment of patients with type 2 diabetes mellitus. GLP-1 is a naturally-occurring peptide hormone that is re...

Acino erzielt 2012 einen Reingewinn von 9,4 Mio EUR

Basel - Das Pharma-Unternehmen Acino weist für das Geschäftsjahr 2012 akquisitionsbedingt zwar deutlich höhere Zahlen aus. Auf operativer Ebene mussten allerdings Ende Januar die Erwartungen nach ....

Acino-Aktie: Pharmazeutika "Made in Switzerland" kommt in den Emerging-Markets gut an

Hamburg - Die Experten vom "Hanseatischen Börsendienst" haben in ihrer aktuellen Ausgabe die Acino-Aktie (ISIN CH0021190902/ WKN A0EAGS) als Neuempfehlung vorgestellt und raten zum Kauf.Das Pharmau.....

Human medicines European Public Assessment Report (EPAR): Clopidogrel Acino Pharma, clopidogrel, Revision: 1, Withdrawn

Human medicines European Public Assessment Report (EPAR): Clopidogrel Acino Pharma GmbH, clopidogrel, Revision: 1, Withdrawn

Does Your Oncologist Care?

By Peter Ubel, MD Facing advanced cancer, who among us wouldn’t look to our oncologist for expert advice on whether another round of chemotherapy makes sense?  But do you know what your oncologist...

1-800-Oncologist launches Contributing Expert program

1-800-Oncologist, Inc. announced today the launch of its Contributing Expert program for oncology and radiology specialists. Members of 1-800-Oncologist's national Contributing Expert network are key...

When It Comes to Cancer, Are You in the Know?

For two million cancer patients and caregivers, 1-800-Oncologist has become the go-to resource for trusted cancer information. Austin, TX (PRWEB) July 26, 2012 1-800-Oncologist, Inc. announced today...

Reps struggle to get through oncologist doors

Reps struggle to get through oncologist doors

Referral Rate to Oncologists and its Variation by Hospital for Colorectal Cancer Patients.

BACKGROUND: Recent population-based studies in Alberta, Canada, found that approximately 50% of patients with stage III colon or stages II/III rectal adenocarcinoma did not receive guideline-recommend...

Comment about the article "Psychopharmaceuticals and diabetes" of Ress C, Tschoner A, Kaser S, and Ebenbichler CF in Wiener Medizinische Wochenschrift 2011; 161/21-22: 531-42.

Effect of patient and patient-oncologist relationship characteristics on communication about health-related quality of life.

Objective: To test the effects of patient and patient-oncologist relationship factors on the time spent communicating about health-related quality of life (HRQOL) during outpatient clinic encounters b...

The Full Burden of Cancer.

Treatment Beyond Progression: Is It Moving from Belief to Evidence?